Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06287203
Status:
RECRUITING
Last Update Posted:
2024-05-17
First Post:
2024-02-21
Brief Title:
Novel Prevention Intervention Program to Reduce Risky Patterns of Substance Use Among Emerging Adults
Sponsor:
Rutgers The State University of New Jersey
Organization:
Rutgers The State University of New Jersey
Study Overview
Official Title:
Novel Prevention Intervention Program to Reduce Risky Patterns of Substance Use Among Emerging Adults
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ARFP
Brief Summary:
The purpose of this research study is to test whether completion of a new personalized feedback program is associated with reductions in risky substance use among emerging adults 18-25 years of age
Detailed Description:
There has been tremendous advances in gene identification From large-scale well-powered genome wide association studies GWAS polygenic scores PGS can now be calculated that sum risk alleles across the genome and weight them by their effect size creating an index of genetic liability for any given individual But genetic influences are only part of what contributes to substance use disorders the environment also plays a critical role Accordingly understanding the development of substance use outcomes necessitates integrating both genetic and environmental information The rationale for this line of research is that the integration of genetic and environmental information will provide the foundation for precision medicine and that the provision of this personalized risk information will help prevent the development of problems andor allow for earlier intervention before problems have become severe Our research team is creating a new preventionintervention program consisting of an on-line platform for individuals to receive their personalized risk estimates for addiction risk created by integrating information about their genetic behavioral and environmental risk factors followed by information about how to reduce risk
The investigators are enrolling a sample of emerging adults 18-25 years of age into a randomized controlled trial consisting of 4 conditions All four conditions will involve completion of a behavioralenvironmental risk survey and the provision of saliva to determine genetic risk Three active conditions involve individuals receiving their personalized risk estimates followed by condition 1 psychoeducation about ways to reduce substance use and associated harm condition 2 the on-line CBT-based module to assist with controlling substance use or condition 3 a follow-up appointment with a genetic counselor GC The fourth condition will be a waitlist control in which individuals will receive psychoeducation only at the time that the active conditions receive their personalized risk estimates
At the first time point T0 participants will be randomly selected into one of four conditions Participants have an equal chance of being assigned to any one of the conditions Across all conditions the investigators will measure substance use and problems at enrollment T0 at the time of receipt of risk estimates 8 weeks later or at the time other participants receive their results 8 weeks later in the case of control condition T1 1 month T2 and 3 months T3 after completion of the program
After the final survey T3 participants in the control condition will receive their personalized risk estimates All participants regardless of their initial group will be invited to receive access to the content of conditions in which they did not take part eg online modules appointment with a genetic counselor
Findings from this study have great potential to enhance our ability to use precision medicine to prevent the development of substance use disorders andor intervene earlier in the progression to disorder
The investigators are enrolling a sample of emerging adults 18-25 years of age into a randomized controlled trial consisting of 4 conditions All four conditions will involve completion of a behavioralenvironmental risk survey and the provision of saliva to determine genetic risk Three active conditions involve individuals receiving their personalized risk estimates followed by condition 1 psychoeducation about ways to reduce substance use and associated harm condition 2 the on-line CBT-based module to assist with controlling substance use or condition 3 a follow-up appointment with a genetic counselor GC The fourth condition will be a waitlist control in which individuals will receive psychoeducation only at the time that the active conditions receive their personalized risk estimates
At the first time point T0 participants will be randomly selected into one of four conditions Participants have an equal chance of being assigned to any one of the conditions Across all conditions the investigators will measure substance use and problems at enrollment T0 at the time of receipt of risk estimates 8 weeks later or at the time other participants receive their results 8 weeks later in the case of control condition T1 1 month T2 and 3 months T3 after completion of the program
After the final survey T3 participants in the control condition will receive their personalized risk estimates All participants regardless of their initial group will be invited to receive access to the content of conditions in which they did not take part eg online modules appointment with a genetic counselor
Findings from this study have great potential to enhance our ability to use precision medicine to prevent the development of substance use disorders andor intervene earlier in the progression to disorder
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 3R01DA050721-04S1 | NIH | None | httpsreporternihgovquickSearch3R01DA050721-04S1 |